US Stock MarketDetailed Quotes
AMRX Amneal Pharmaceuticals
- 8.460
- -0.190-2.20%
Close Oct 7 16:00 ET
- 8.460
- 0.0000.00%
Post 16:20 ET
2.62BMarket Cap-10708P/E (TTM)
8.660High8.390Low950.54KVolume8.620Open8.650Pre Close8.06MTurnover0.67%Turnover RatioLossP/E (Static)309.54MShares8.94052wk High-45.48P/B1.20BFloat Cap3.36052wk Low--Dividend TTM141.38MShs Float24.480Historical High--Div YieldTTM3.12%Amplitude1.240Historical Low8.475Avg Price1Lot Size
Amneal Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 449.55%39.66M | -103.16%-4.41M | 430.84%345.58M | 683.13%135.82M | -13.02%81.39M | 90.96%-11.35M | 16.09%139.71M | -73.08%65.1M | -136.82%-23.29M | 13.61%93.57M |
| Net income from continuing operations | -43.45%16.79M | -709.17%-81.68M | 80.88%-48.72M | -1,493.44%-93.34M | 1,147.41%25.03M | 112.36%29.68M | -56.25%-10.09M | -1,363.21%-254.79M | 71.37%-5.86M | 60.77%-2.39M |
| Operating gains losses | 33.57%569K | 176.04%1.51M | -105.06%-768K | -216.20%-2.33M | -35.97%3.12M | -91.75%426K | -163.28%-1.99M | 8,580.00%15.19M | 645.72%2.01M | 2,338.07%4.88M |
| Depreciation and amortization | -2.69%55.57M | -4.51%55.53M | -4.49%229.4M | -6.75%56.93M | -7.15%57.21M | -4.33%57.11M | 0.58%58.15M | 2.90%240.18M | -0.21%61.06M | 2.36%61.61M |
| Other non cash items | 28.43%-1.85M | -75.04%1.64M | 154.59%44.41M | 401.19%31.95M | 97.19%8.49M | -180.26%-2.58M | 84.85%6.56M | 14.86%17.45M | 678.40%6.37M | -52.46%4.3M |
| Change In working capital | 52.90%-56.72M | -122.06%-11.97M | 21.28%-47.19M | 139.72%53.7M | -712.66%-34.74M | -735.91%-120.43M | 7.16%54.28M | 55.13%-59.95M | -521.76%-135.21M | 331.81%5.67M |
| -Change in receivables | 21.98%-100.74M | -128.37%-55.74M | 259.10%125.8M | 169.45%77.88M | -132.46%-19.4M | 14.49%-129.11M | 58.07%196.44M | -384.80%-79.07M | -225.89%-112.12M | 150.32%59.77M |
| -Change in inventory | 38.85%-23.25M | 45.80%-12.2M | -23.23%-126.18M | -108.58%-23.09M | -64.15%-42.57M | 4.59%-38.02M | 11.90%-22.51M | -108.91%-102.4M | -166.57%-11.07M | -134.39%-25.93M |
| -Change in prepaid assets | 20.16%3.29M | -140.15%-11.71M | 282.66%37.81M | -70.62%13M | -108.30%-7.09M | 102.37%2.74M | 759.28%29.16M | 144.96%9.88M | 703.01%44.26M | 2,535.58%85.37M |
| -Change in payables and accrued expense | 45.52%63.98M | 145.47%67.67M | -175.79%-84.62M | 74.96%-14.09M | 130.23%34.32M | -86.48%43.96M | -240.96%-148.81M | 341.19%111.64M | -493.57%-56.28M | -865.71%-113.54M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 449.55%39.66M | -103.16%-4.41M | 430.84%345.58M | 683.13%135.82M | -13.02%81.39M | 90.96%-11.35M | 16.09%139.71M | -73.08%65.1M | -136.82%-23.29M | 13.61%93.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 47.37%-6.47M | -68.36%-19.76M | 60.31%-69.19M | -176.40%-31.69M | 72.68%-13.48M | 23.78%-12.28M | 87.95%-11.74M | 10.23%-174.31M | 86.82%-11.47M | -324.07%-49.33M |
| Net PPE purchase and sale | 3.86%-10.7M | 11.75%-10.06M | 4.09%-46.8M | -2.84%-11.79M | 28.84%-12.48M | -56.46%-11.13M | 10.11%-11.4M | 4.21%-48.8M | 36.49%-11.47M | -50.71%-17.53M |
| Net intangibles purchase and sale | 34.78%-750K | -2,769.82%-9.7M | 46.44%-22.39M | ---19.9M | 96.86%-1M | 88.50%-1.15M | ---338K | -2,358.82%-41.8M | --0 | ---31.8M |
| Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 42.19%-84.71M | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.00%1M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 47.37%-6.47M | -68.36%-19.76M | 60.31%-69.19M | -176.40%-31.69M | 72.68%-13.48M | 23.78%-12.28M | 87.95%-11.74M | 10.23%-174.31M | 86.82%-11.47M | -324.07%-49.33M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -186.28%-35.09M | -79.50%-23.16M | -99.37%-212.57M | -354.87%-100.83M | -87.69%-86.59M | -152.72%-12.26M | 79.05%-12.9M | 22.81%-106.62M | 26.96%-22.17M | -5.92%-46.13M |
| Net issuance payments of debt | -630.06%-27M | -309.47%-15.38M | 159.19%22.65M | 463.44%64.16M | -26.61%-53.94M | -83.98%5.09M | 174.94%7.34M | 51.66%-38.27M | 77.39%-17.65M | -225.78%-42.61M |
| Proceeds from stock option exercised by employees | --358K | --28K | -31.87%451K | --43K | -3.55%408K | --0 | --0 | -22.39%662K | --0 | 176.47%423K |
| Net other financing activities | 51.31%-8.45M | 61.43%-7.81M | -241.51%-235.68M | -3,556.92%-165.04M | -737.32%-33.05M | -100.22%-17.35M | 60.99%-20.24M | -15.41%-69.01M | -109.46%-4.51M | 94.91%-3.95M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -186.28%-35.09M | -79.50%-23.16M | -99.37%-212.57M | -354.87%-100.83M | -87.69%-86.59M | -152.72%-12.26M | 79.05%-12.9M | 22.81%-106.62M | 26.96%-22.17M | -5.92%-46.13M |
| Net cash flow | ||||||||||
| Beginning cash position | -65.83%51.62M | 181.34%99.11M | -86.28%35.23M | -0.30%95.61M | 16.70%114.58M | -30.24%151.07M | -86.28%35.23M | -26.04%256.74M | -69.13%95.89M | -65.33%98.18M |
| Current changes in cash | 94.72%-1.89M | -141.13%-47.33M | 129.57%63.82M | 105.80%3.3M | -885.96%-18.67M | 69.69%-35.89M | 397.95%115.08M | -138.53%-215.83M | -5.30%-56.93M | -106.97%-1.89M |
| Effect of exchange rate changes | 83.22%-101K | -121.51%-165K | 101.14%65K | 105.38%201K | 24.18%-301K | -2,508.00%-602K | 148.79%767K | -5,671.57%-5.68M | -2,200.56%-3.74M | -236.90%-397K |
| End cash Position | -56.69%49.62M | -65.83%51.62M | 181.34%99.11M | 181.34%99.11M | -0.30%95.61M | 16.70%114.58M | -30.24%151.07M | -86.28%35.23M | -86.28%35.23M | -69.13%95.89M |
| Free cash flow | 219.36%28.2M | -118.89%-24.17M | 1,184.09%276.39M | 399.59%104.13M | 53.51%67.91M | 83.43%-23.63M | 18.87%127.98M | -113.48%-25.5M | -178.98%-34.76M | -37.46%44.24M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data